第一单位：
Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria, Egypt; Department of Pharmaceutics, Faculty of Pharmacy, Damanhur University, Damanhur, Egypt; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Harvard-MIT Division of Health Sciences & Technology (HST), Cambridge, MA 02139, USA.
作者：
Mona A,Abdelmoneem [1]
;
Mahmoud M,Abd Elwakil [2]
;
Sherine N,Khattab [3]
;
Maged W,Helmy [4]
;
Adnan A,Bekhit [5]
;
Mohammad A,Abdulkader [6]
;
Amira,Zaky [6]
;
Mohamed,Teleb [7]
;
Kadria A,Elkhodairy [8]
;
Fernando,Albericio [9]
;
Ahmed O,Elzoghby [10]
作者单位：
Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria, Egypt; Department of Pharmaceutics, Faculty of Pharmacy, Damanhur University, Damanhur, Egypt; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Harvard-MIT Division of Health Sciences & Technology (HST), Cambridge, MA 02139, USA.
[1]
Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria, Egypt; Graduate school of Pharmaceutical Sciences, Hokkaido University, Japan.
[2]
Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria, Egypt; Department of Chemistry, Faculty of Science, Alexandria University, Alexandria 21321, Egypt. Electronic address: sh.n.khattab@gmail.com.
[3]
Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria, Egypt; Department of Pharmacology & Toxicology, Faculty of Pharmacy, Damanhur University, Damanhur, Egypt.
[4]
Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria, Egypt; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt; Pharmacy Program, Allied Health Department, College of Health and Sport Sciences, University of Bahrain, P.O. Box 32038, Bahrain.
[5]
Department of Biochemistry, Faculty of Science, Alexandria University, Alexandria 21511, Egypt.
[6]
Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria, Egypt; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
[7]
Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria, Egypt; Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
[8]
School of Chemistry and Physics, University of KwaZulu-Natal, Durban 4001, South Africa; CIBER-BBN, Networking Centre on Bioengineering Biomaterials and Nanomedicine, Barcelona Science Park, Barcelona 08028, Spain; Department of Organic Chemistry, University of Barcelona, Barcelona 08028, Spain.
[9]
Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria, Egypt; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Harvard-MIT Division of Health Sciences & Technology (HST), Cambridge, MA 02139, USA; Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt. Electronic address: aelzoghby@bwh.harvard.edu.
[10]
DOI
10.1016/j.msec.2020.111422
PMID
33255023
发布时间
2021-05-14
换一批
换一批
